Systemic Lupus Erythematosus Stem Cell Treatments
A Regenerative Approach to Autoimmune Balance
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease in which the immune system mistakenly attacks healthy tissues, affecting the skin, joints, kidneys, and other vital organs. Traditional treatments often rely on immunosuppressants and corticosteroids, which help manage symptoms but can cause long-term side effects.
At 1 STEM CELL, we offer an innovative stem cell therapy for lupus designed to restore immune balance and reduce inflammation at its source. Using umbilical cord–derived mesenchymal stem cells (MSCs), our protocol helps modulate immune response, decrease autoantibody activity, and promote tissue regeneration.
Unlike conventional therapies, stem cell treatment aims to address the root cause of immune dysfunction, not just its symptoms — offering patients a chance to improve quality of life, reduce flare-ups, and minimize medication dependence.
Questions and Answers About Stem Cell Therapy for Lupus
Q: How can stem cells help treat lupus?
Mesenchymal stem cells regulate the immune system by suppressing abnormal immune activity while promoting tissue healing. This helps reduce inflammation and damage to organs caused by lupus.
Q: Is this treatment safe?
Yes. At 1 STEM CELL, all stem cells used are ethically sourced and laboratory-tested. Treatments are administered under strict medical supervision to ensure patient safety and optimal outcomes.
Q: How soon can improvements be noticed?
Some patients experience reduced fatigue and joint pain within 4–6 weeks, while organ function improvements and reduced flare frequency may occur gradually over several months.
Q: Does stem cell therapy replace conventional medications?
It may allow a reduction in medication dosage over time, but all changes must be managed by a physician. Stem cell therapy works best as part of a comprehensive, medically supervised plan.
Q: Who qualifies for lupus stem cell therapy?
Candidates include patients with moderate to severe lupus who have not responded well to standard treatments or seek regenerative alternatives to long-term drug therapy.